Literature DB >> 35226235

The role of surgery in the treatment of metastatic bone tumor.

Katsuhiro Hayashi1, Hiroyuki Tsuchiya2.   

Abstract

Surgery for bone metastasis has two primary goals-palliative care to relieve pain, instability and paralysis, and tumor resection for curing the disease. Oncologically en bloc resection, followed by a reconstruction of the bone defect is the treatment of choice in single bone metastasis from renal cell carcinoma or thyroid cancer. Bone metastases may occur in the extremities, pelvis, or spine, and different resection and reconstruction methods depend on the regional anatomy. For instance, multiple options are available for reconstruction of the pelvis, especially for the acetabulum, including anatomical reconstruction using custom-made implants or recycled autologous bone grafting when a long-term prognosis is expected. Recently, for the spine, total en bloc spondylectomy is extensively performed despite the initial limitations of surgical invasiveness, such as blood loss. Principally, palliative surgery aims to maintain lasting bony stability with minimal surgical invasiveness. Intramedullary nails and plate fixation are frequently used in the extremities but the postoperative failure rate is relatively high. Therefore, surgeons should consider the use of long intramedullary nails and long-type stems for endoprosthesis reconstruction along with cement fixation to reduce the failure rate. Although short-term complications, such as dislocation, have been observed with endoprosthesis reconstruction, it is stable in the long-term follow-up. Percutaneous bone cement injection into the spine and pelvis is also effective and less invasive.
© 2022. The Author(s) under exclusive licence to Japan Society of Clinical Oncology.

Entities:  

Keywords:  Bone metastasis; Bone reconstruction; Curative surgery; En bloc resection; Oligometastases; Palliative surgery

Mesh:

Year:  2022        PMID: 35226235     DOI: 10.1007/s10147-022-02144-6

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.850


  62 in total

1.  Total en bloc spondylectomy for spinal metastases in thyroid carcinoma.

Authors:  Satoru Demura; Norio Kawahara; Hideki Murakami; Mohamed E Abdel-Wanis; Satoshi Kato; Katsuhito Yoshioka; Katsuro Tomita; Hiroyuki Tsuchiya
Journal:  J Neurosurg Spine       Date:  2010-12-24

2.  Oligometastases.

Authors:  S Hellman; R R Weichselbaum
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

3.  High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome.

Authors:  Antoine Brouquet; Eddie K Abdalla; Scott Kopetz; Christopher R Garrett; Michael J Overman; Cathy Eng; Andreas Andreou; Evelyne M Loyer; David C Madoff; Steven A Curley; Jean-Nicolas Vauthey
Journal:  J Clin Oncol       Date:  2011-01-24       Impact factor: 44.544

4.  Benefit of surgical resection of distant metastasis in soft tissue sarcoma: a systematic review.

Authors:  Katsuhiro Hayashi; Koji Hiraoka; Toru Akiyama; Shintaro Iwata; Hiroyuki Tsuchiya; Akira Kawai
Journal:  Jpn J Clin Oncol       Date:  2021-04-06       Impact factor: 3.019

Review 5.  Osteosarcoma.

Authors:  J Ritter; S S Bielack
Journal:  Ann Oncol       Date:  2010-10       Impact factor: 32.976

6.  Resection of metastatic renal cell carcinoma.

Authors:  J P Kavolius; D P Mastorakos; C Pavlovich; P Russo; M E Burt; M S Brady
Journal:  J Clin Oncol       Date:  1998-06       Impact factor: 44.544

7.  Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels.

Authors:  Katsuhiro Hayashi; Ping Jiang; Kensuke Yamauchi; Norio Yamamoto; Hiroyuki Tsuchiya; Katsuro Tomita; A R Moossa; Michael Bouvet; Robert M Hoffman
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

Review 8.  Current treatment modalities for spinal metastases secondary to thyroid carcinoma.

Authors:  Yevgeniya S Kushchayeva; Sergiy V Kushchayev; Jason A Wexler; Nancy M Carroll; Mark C Preul; Oleg M Teytelboym; Volker K H Sonntag; Douglas Van Nostrand; Kenneth D Burman; Lisa M Boyle
Journal:  Thyroid       Date:  2014-07-23       Impact factor: 6.568

9.  Skeletal-related events due to bone metastases from differentiated thyroid cancer.

Authors:  Azeez Farooki; Vivien Leung; Hernan Tala; R Michael Tuttle
Journal:  J Clin Endocrinol Metab       Date:  2012-05-07       Impact factor: 5.958

Review 10.  Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions.

Authors:  Felipe Couñago; Javier Luna; Luis Leonardo Guerrero; Blanca Vaquero; María Cecilia Guillén-Sacoto; Teresa González-Merino; Begoña Taboada; Verónica Díaz; Belén Rubio-Viqueira; Ana Aurora Díaz-Gavela; Francisco José Marcos; Elia Del Cerro
Journal:  World J Clin Oncol       Date:  2019-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.